Bariatric Surgeon Perspective on Revisional Bariatric Surgery (RBS) for Weight Recurrence.


Journal

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
ISSN: 1878-7533
Titre abrégé: Surg Obes Relat Dis
Pays: United States
ID NLM: 101233161

Informations de publication

Date de publication:
09 2023
Historique:
received: 17 10 2022
revised: 14 02 2023
accepted: 24 02 2023
medline: 4 9 2023
pubmed: 16 4 2023
entrez: 15 4 2023
Statut: ppublish

Résumé

Weight recurrence (WR) after bariatric surgery occurs in nearly 20% of patients. Revisional bariatric surgery (RBS) may benefit this population but remains controversial among surgeons. Explore surgeon perspectives and practices for patients with WR after primary bariatric surgery (PBS). Web-based survey of bariatric surgeons. A 21-item survey was piloted and posted on social media closed groups (Facebook) utilized by bariatric surgeons. Survey items included demographic information, questions pertaining to the definition of suboptimal and satisfactory response to bariatric surgery, and general questions related to different WR management options. One hundred ten surgeons from 19 countries responded to the survey. Ninety-eight percent responded that WR was multifactorial, including behavioral and biological factors. Failure of PBS was defined as excess weight loss < 50% by 31.4%, as excess weight loss <25% by 12.8%, and as comorbidity recurrence by 17.4%. Surgeon responses differed significantly by gender (P = .036). 29.4% believed RBS was not successful, while 14.1% were unsure. Nevertheless, 73% reported that they would perform RBS if sufficient evidence of benefit existed. Most frequently performed revisional procedures included conversion of sleeve gastrectomy to Roux-en-Y gastric bypass (RYGB), adjustable gastric band to RYGB, and RYGB revision (21.9% versus 18.2% versus 15.3%, respectively). This survey demonstrates significant variability in surgeon perception regarding causes and the effectiveness of RBS. Moreover, they disagree on what constitutes a nonsatisfactory response to PBS and to whom they offer RBS. These findings may relate to limited available clinical evidence on best management options for this patient population. Clinical trials investigating the comparative effectiveness of various treatment options are needed.

Sections du résumé

BACKGROUND
Weight recurrence (WR) after bariatric surgery occurs in nearly 20% of patients. Revisional bariatric surgery (RBS) may benefit this population but remains controversial among surgeons.
OBJECTIVES
Explore surgeon perspectives and practices for patients with WR after primary bariatric surgery (PBS).
SETTING
Web-based survey of bariatric surgeons.
METHODS
A 21-item survey was piloted and posted on social media closed groups (Facebook) utilized by bariatric surgeons. Survey items included demographic information, questions pertaining to the definition of suboptimal and satisfactory response to bariatric surgery, and general questions related to different WR management options.
RESULTS
One hundred ten surgeons from 19 countries responded to the survey. Ninety-eight percent responded that WR was multifactorial, including behavioral and biological factors. Failure of PBS was defined as excess weight loss < 50% by 31.4%, as excess weight loss <25% by 12.8%, and as comorbidity recurrence by 17.4%. Surgeon responses differed significantly by gender (P = .036). 29.4% believed RBS was not successful, while 14.1% were unsure. Nevertheless, 73% reported that they would perform RBS if sufficient evidence of benefit existed. Most frequently performed revisional procedures included conversion of sleeve gastrectomy to Roux-en-Y gastric bypass (RYGB), adjustable gastric band to RYGB, and RYGB revision (21.9% versus 18.2% versus 15.3%, respectively).
CONCLUSIONS
This survey demonstrates significant variability in surgeon perception regarding causes and the effectiveness of RBS. Moreover, they disagree on what constitutes a nonsatisfactory response to PBS and to whom they offer RBS. These findings may relate to limited available clinical evidence on best management options for this patient population. Clinical trials investigating the comparative effectiveness of various treatment options are needed.

Identifiants

pubmed: 37061437
pii: S1550-7289(23)00121-1
doi: 10.1016/j.soard.2023.02.027
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

972-979

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Spyridon Giannopoulos (S)

Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.

Panagiotis Kapsampelis (P)

Department of Surgery, Kingston Hospital NHS Foundation Trust, Kingston-upon-Thames, UK.

Bhavani Pokala (B)

Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.

Jill D Nault Connors (JD)

Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.

William Hilgendorf (W)

Indiana University Health North Hospital, Carmel, Indiana.

Lava Timsina (L)

Department of Surgery, Center for Outcomes Research in Surgery, Indiana University School of Medicine, Indianapolis, IN.

Benjamin Clapp (B)

Paul Foster School of Medicine, Texas Tech HSC, El Paso, Texas.

Omar Ghanem (O)

Department of Surgery, Mayo Clinic, Rochester, Minnesota.

Tammy L Kindel (TL)

Department of Surgery, Medical College of Wisconsin, Wauwatosa, WI.

Dimitrios Stefanidis (D)

Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: dimstefa@iu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH